ArticleAACE endocrinology and diabetes
Sarcoidosis-Induced Hypercalcemia in a Patient With Multiple Endocrine Neoplasia Type 2A (MEN2A) Syndrome Harboring the C609Y REarranged During Transfection (RET) Mutation.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Hypercalcemia is a common clinical manifestation of Multiple Endocrine Neoplasia 2A (MEN 2A) through primary hyperparathyroidism.The objective of this report is to describe a rare and unique case of sarcoidosis-related hypercalcemia in a patient with a history of MEN2A. Case Report: A 59-year-old female with past medical history of MEN2A, REarranged during Transfection mutation C609Y, diagnosed in 2007 status post-total thyroidectomy presented to the hospital with an acute abdominal pain aggravated with eating. Review of systems was significant for a 40 lbs. weight loss, fatigue, dry mouth, and polydipsia. Computed tomography (CT) abdomen showed liver and spleen nodules and a few mildly enlarged retroperitoneal lymph nodes. CT chest noted enlarged left axillary lymph nodes but otherwise no enlarged mediastinal lymph nodes. Blood work showed a calcium level of 13.6 [8.5-10.3 mg/dl], intact parathyroid hormone: 6.3 [10-65 pg/mL], 25-OH vitamin D level: 21.5 [18-50 ng/mL], 1,25-vitamin D: 51 [18-64 pg/mL]. Liver biopsy showed noncaseating granuloma. Positron emission tomography-computed tomography showed hypodense splenic nodules, heterogenous liver, diffuse pancreatic atrophy, and lack of abnormal neck/lung adenopathy. The patient was then referred to rheumatology for evaluation for sarcoidosis. Angiotensin-converting enzyme level was 124. Patient was managed acutely with calcitonin and was started on prednisone and hydroxychloroquine. Calcium level normalized. Discussion: The co-occurrence of both MEN 2A and sarcoidosis is rare, adding an unexpected layer of complexity to the diagnosis. Conclusion: The rarity of sarcoidosis co-occurring with MEN 2A highlights the importance of considering a broad differential diagnosis, even in patients with known genetic syndromes, to ensure accurate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.